A7807512
(3R,4S)-Tofacitinib , 98% , 1092578-46-5
| Pack Size | Price | Stock | Quantity |
| 10MG | RMB1599.20 | In Stock |
|
| 50MG | RMB4799.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | >108°C (dec.) |
| Density | 1.296 |
| storage temp. | Refrigerator |
| solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly, Heated) |
| form | Solid |
| pka | 6.04±0.60(Predicted) |
| color | Pale Yellow to Yellow |
| InChI | InChI=1/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13-/s3 |
| InChIKey | UJLAWZDWDVHWOW-PZILLZCRNA-N |
| SMILES | C(#N)CC(N1CC[C@H](C)[C@@H](N(C)C2=NC=NC3NC=CC=32)C1)=O |&1:7,9,r| |
Description and Uses
(3R,4S)-Tofacitinib is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
Safety
| Symbol(GHS) | ![]() ![]() GHS07,GHS08 |
| Signal word | Danger |
| Hazard statements | H302-H360 |
| Precautionary statements | P201-P202-P264-P270-P281-P301+P312-P308+P313-P330-P405-P501 |






![4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine](https://img.chemicalbook.com/CAS/GIF/479633-63-1.gif)

